TCON
TRACON Pharmaceuticals, Inc. Common Stock
TCON
TCON
Delisted
TCON was delisted on the 27th of June, 2024.
33 hedge funds and large institutions have $16.4M invested in TRACON Pharmaceuticals, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
Holders
33
Holding in Top 10
1
Calls
$52K
Puts
–
Top Buyers
| 1 | +$108K | |
| 2 | +$35K | |
| 3 | +$33.8K | |
| 4 |
Renaissance Technologies
New York
|
+$25.5K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$22K |
Top Sellers
| 1 | -$99.8K | |
| 2 | -$67.6K | |
| 3 | -$38.9K | |
| 4 |
Jane Street
New York
|
-$20K |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$15.8K |